Showing results (211-220 of 234) with videos related to
Sort By:
Pageof 24
Frontiers in Oncology|June 9, 2020
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder CancerYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|February 20, 2022
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinomaYoko Koh, Kosuke Nakano, Kotoe Katayama, et al.Nature Communications|December 7, 2023
Pressure-induced reversal of Peierls-like distortions elicits the polyamorphic transition in GeTe and GeSeTomoki Fujita, Yuhan Chen, Yoshio Kono, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|October 28, 2022
Diagnostic and prognostic significance of tartrate-resistant acid phosphatase type 5b in newly diagnosed prostate cancer with bone metastasis: A real-world multi-institutional studyGaku Yamamichi, Taigo Kato, Satoru Yumiba, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|December 29, 2022
A comparative study on nivolumab and axitinib as secondary treatment in patients with metastatic renal cell carcinoma: A multi-institutional retrospective study in JapanTaigo Kato, Satoru Yumiba, Wataru Nakata, et al.The Prostate|August 29, 2017
Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a predictive factor of adverse pathology in radical prostatectomy specimensTakuji Hayashi, Kazutoshi Fujita, Satoshi Nojima, et al.The Journal of Physiology|July 27, 2014
Ano1, a Ca2+-activated Cl- channel, coordinates contractility in mouse intestine by Ca2+ transient coordination between interstitial cells of CajalRaman Deep Singh, Simon J Gibbons, Siva Arumugam Saravanaperumal, et al.Anticancer Research|September 4, 2020
A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell CarcinomaTaigo Kato, Eisuke Tomiyama, Yoko Koh, et al.Cancer Science|March 15, 2021
Proteomic analysis of urinary and tissue-exudative extracellular vesicles to discover novel bladder cancer biomarkersEisuke Tomiyama, Kyosuke Matsuzaki, Kazutoshi Fujita, et al.Cancer Science|March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.Pageof 24